COYA ▲ +7.2% - Coya Therapeutics, Inc.
$COYA - Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
05-OCT-2026 08:04 AM ET
Share this post
More filings for $COYA
View full $COYA filing history →💬 Comments
Loading comments…
Leave a comment
